Coronavirus (Covid-19)

Original Article Oral Lopinavir–Ritonavir for Severe Covid-19 Investigators in China report the results of an open-label, randomized clinical trial of lopinavir–ritonavir for the treatment of Covid-19 in 199 infected adult patients. The primary end point was the time to clinical improvement. Allocating Scarce Medical Resources for Covid-19 The Covid-19 […]

Click here to view original web page at www.nejm.or

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.